• Return to Headlines

Shares of MYGN Down 17.5% Since Downtrend Call on Shares

By James Quinn

SmarTrend identified a Downtrend for Myriad Genetics (NASDAQ:MYGN) on February 5th, 2018 at $35.24. In approximately 2 months, Myriad Genetics has returned 17.52% as of today's recent price of $29.07.

In the past 52 weeks, Myriad Genetics share prices have been bracketed by a low of $15.15 and a high of $41.57 and are now at $29.07, 92% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.3% while the 50-day MA has declined 0.5%.

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Myriad Genetics.

Log in and add Myriad Genetics (MYGN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights myriad genetics

Ticker(s): MYGN